FDA Orange Book · active-ingredient family
Molindone hydrochloride
Molindone hydrochloride is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:MOBAN · NDA 017111
2
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, concentrate, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MOBANRLD×8 | CHARTWELL RX | NDA 017111 | — | Approved Prior to Jan 1, 1982 | |
| MOBAN | ENDO PHARMS | NDA 017938 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| MOLINDONE HYDROCHLORIDE×3 | EPIC PHARMA LLC | ANDA 090453 | — | Mar 20, 2015 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Molindone hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

